홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

4-(1-Benzylpiperidin-4-yl)morpholine → 4-Morpholinopiperidine

HRID 642910
인쇄

반응식

HRID 642910 반응식
C1(C[N:8]2[CH2:13][CH2:12][CH:11]([N:14]3[CH2:19][CH2:18][O:17][CH2:16][CH2:15]3)[CH2:10][CH2:9]2)C=CC=CC=1.[H][H]>CO.[Pd]>[NH:8]1[CH2:13][CH2:12][CH:11]([N:14]2[CH2:19][CH2:18][O:17][CH2:16][CH2:15]2)[CH2:10][CH2:9]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 7838314-(1-Benzylpiperidin-4-yl)morpholineHCID 178418361HCID 178418361, 화합물

생성물 1

HCID 7957244-Morpholinopiperidine

시약·촉매·용매 2

HCID 23938Palladium촉매HCID 887Methanol용매

실험 절차

41.59 g (0.16 Mol) 4-[1-(phenylmethyl)-4-piperidinyl]-morpholine (N) are dissolved in 400 mL methanol, combined with 5.2 g palladium on activated charcoal (10%) and hydrogenated for 18 hours at ambient temperature with 50 psi hydrogen. The catalyst is filtered off and the filtrate is evaporated down. A colourless oil remains, which crystallises after a short time.

후처리

  1. filtrationThe catalyst is filtered off
  2. customthe filtrate is evaporated down
  3. customA colourless oil remains, which crystallises after a short time

출처 및 근거

ORD 기록
ord-002e7a9350934f3ca9561e62fd89d388
출처 데이터셋
uspto-grants-2010_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07696346B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트